Psychotische Dekompensation, Substanzkonsum oder serotonerges Syndrom?

Zusammenfassung

Ein junger Patient mit paranoider Schizophrenie, Abhängigkeitserkrankung und schwerer depressiver Episode entwickelt ein serotonerges Syndrom während einer Kombinationsbehandlung mit Sertralin und Ziprasidon. Die korrekte diagnostische Einordnung der klinischen Symptome ist, obwohl häufig schwierig, von größter Bedeutung.

Abstract

A young male with schizophrenia, dependence syndrome (multiple drug use) and a severe depressive episode develops a serotonin syndrome with Sertraline and Ziprasidone. Making the correct diagnosis, although potentially challenging, remains vital.

Schlüsselwörter

Serotoninsyndrom - Ziprasidon - Sertralin - SSRI - atypische Neuroleptika

Keywords

serotonin syndrome - ziprasidone - sertraline - SSRI - atypical antipsychotics

• Literatur

• 1 Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975; 234: 1236-1241
• 2 Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705-713
• 3 Dunkley EJC, Isbister GK, Sibbritt D. et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635-642
• 4 Minov C. QTc-Zeitverlängerung unter Ziprasidon in Kombination mit Quetiapin. Psychiat Prax 2004; 31: 142-144
• 5 Schmidt AW, Lebel LA, Howard Jr HR. et al. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 2001; 425: 197-201
• 6 Spina E, Scordo MG, D’Arrigo C. Metabolic drug interactions with new psychotropic agents. Fundam Clin Pharmacol 2003; 17: 517-538
• 7 Papakostas GI, Petersen TJ, Nierenberg AA. et al. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J Clin Psychiatry 2004; 65: 217-221
• 8 Dunner DL, Amsterdam JD, Shelton RC. et al. Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. J Clin Psychiatry 2007; 68: 1071-1077
• 9 Moeller O, Evers S, Deckert J. et al. The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1440-1443
• 10 Kellner M, Muhtz C, Wiedemann K. Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial?. J Clin Psychopharmacol 2010; 30: 471-473
• 11 Palekar N, Eisman J. Serotonin syndrome with ziprasidone and sertraline. J Neuropsychiatry Clin Neurosci 2013; 25: E1